Blood Transfusion Diagnostics Market Size was estimated at USD 4.70 billion in 2022 and is poised to reach at 8.38 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 7.2% for the forecast period of 2023-2030.

The Blood Transfusion Diagnostics Market Share is a rapidly growing sector in the healthcare industry, driven by the increasing demand for safe and reliable blood transfusions. This market encompasses a range of diagnostic tests and technologies that are used to ensure compatibility between blood donors and recipients, minimize the risk of transfusion-related complications, and improve patient outcomes.

One of the key factors driving the growth of this market is the rising number of blood transfusions performed worldwide. Blood transfusions are essential in various medical procedures, including surgeries, trauma management, cancer treatments, and organ transplants. As the prevalence of these conditions continues to rise, so does the need for accurate and efficient transfusion diagnostics.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2968

Another significant driver is the increasing awareness about blood safety among healthcare providers and patients. With growing concerns about infectious diseases such as HIV/AIDS, hepatitis B and C, Zika virus, and emerging pathogens like COVID-19, there is a heightened focus on ensuring that donated blood is thoroughly screened for potential infections.

KEY MARKET SEGMENTS

By Product

  • Consumables
  • Instruments
  • Services

By Technique

  • PCR-based and Microarray Techniques
  • Assay-based Techniques
  • Massively Parallel Sequencing Techniques
  • Other Techniques

By Test Type

  • Antibody Screening
  • HLA Typing
  • Cross-matching Tests
  • ABO Blood Tests
  • Antigen Typing

Major Players Listed in the Report are as Follows:

Grifols, S.A.; Merck KGaA; Bio-Rad Laboratories, Inc.; Immucor, Inc.; Novacyt Group; Danaher Corporation; Agena Bioscience, Inc.; Ortho Clinical Diagnostics; and Quotient, Ltd., and others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)